首页> 外文期刊>Molecular pharmacology. >Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation.
【24h】

Role for the regulator of G-protein signaling homology domain of G protein-coupled receptor kinases 5 and 6 in beta 2-adrenergic receptor and rhodopsin phosphorylation.

机译:G蛋白偶联受体激酶5和6的G蛋白信号同源结构域的调节剂在β2肾上腺素受体和视紫红质磷酸化中的作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Phosphorylation of G protein-coupled receptors (GPCRs) by GPCR kinases (GRKs) is a major mechanism of desensitization of these receptors. GPCR activation of GRKs involves an allosteric site on GRKs distinct from the catalytic site. Although recent studies have suggested an important role of the N- and C-termini and domains surrounding the kinase active site in allosteric activation, the nature of that site and the relative roles of the RH domain in particular remain unknown. Based on evolutionary trace analysis of both the RH and kinase domains of the GRK family, we identified an important cluster encompassing helices 3, 9, and 10 in the RH domain in addition to sites in the kinase domain. To define its function, a panel of GRK5 and -6 mutants was generated and screened by intact-cell assay of constitutive GRK phosphorylation of the beta(2)-adrenergic receptor (beta 2AR), in vitro GRK phosphorylation of light-activated rhodopsin, and basal catalytic activity measured by tubulin phosphorylation and autophosphorylation. A number of double mutations within helices 3, 9, and 10 reduced phosphorylation of the beta2AR and rhodopsin by 50 to 90% relative to wild-type GRK, as well as autophosphorylation and tubulin phosphorylation. Based on these results, helix 9 peptide mimetics were designed, and several were found to inhibit rhodopsin phosphorylation by GRK5 with an IC(50) of approximately 30 microM. In summary, our studies have uncovered previously unrecognized functionally important sites in the regulator of G-protein signaling homology domain of GRK5 and -6 and identified a peptide inhibitor with potential for specific blockade of GRK-mediated phosphorylation of receptors.
机译:GPCR激酶(GRK)使G蛋白偶联受体(GPCR)磷酸化是这些受体脱敏的主要机制。 GRK的GPCR激活涉及GRK上的一个变构位点,该位点不同于催化位点。尽管最近的研究表明,N-末端和C-末端以及激酶活性位点周围的结构域在变构激活中起着重要作用,但是该位点的性质以及RH结构域的相对作用仍然未知。基于对GRK家族的RH和激酶结构域的进化轨迹分析,我们确定了一个重要的簇,除了在激酶结构域中的位点外,还包含RH域中的螺旋3、9和10。为了定义其功能,生成了一组GRK5和-6突变体,并通过完整细胞测定法对β(2)-肾上腺素受体(β2AR)进行了组成性GRK磷酸化,光活化视紫红质的体外GRK磷酸化进行了筛选通过微管蛋白的磷酸化和自磷酸化来测定基础催化活性。螺旋3、9和10中的许多双突变使β2AR和视紫红质的磷酸化相对于野生型GRK降低了50%至90%,以及自磷酸化和微管蛋白的磷酸化。根据这些结果,设计了螺旋9肽模拟物,发现其中的几种模拟物可抑制GRK5抑制视紫红质的磷酸化,其IC(50)约为30 microM。总而言之,我们的研究发现了GRK5和-6的G蛋白信号同源结构域的调节子中先前无法识别的功能重要位点,并确定了一种可能特异性阻断GRK介导的受体磷酸化的肽抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号